Non-Vascular Guidewire
- UID
- IMP/MD/2018/000059_b0d4afb688dc6df2c063b17ec78b9d88_d9ad5cd9d3aa8cab6ac172c31fc2623b
- Device class
- Class B
- Brand name
- Interject Contrast Injection Therapy Needle Catheter
- License holder
- Boston Scientific India Pvt. Ltd.,
- Approving authority
- CDSCO
- Product information
- The Jagwire Revolution High Performance Guidewire is indicated for use in selective cannulation of the biliary ducts including the common bile duct, pancreatic duct, cystic duct, and right and left hepatic ducts. The endoscopic guidewire is designed to be used during endoscopic pancreatico-biliary procedures for catheter introduction, exchanges of catheters, cannulas, and sphincterotomes, and to aid in the placement of diagnostic and therapeutic devices
Non-Vascular Guidewire is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2018/000059_b0d4afb688dc6df2c063b17ec78b9d88_d9ad5cd9d3aa8cab6ac172c31fc2623b. This device is marketed under the brand name Interject Contrast Injection Therapy Needle Catheter. The license holder is Boston Scientific India Pvt. Ltd.,, and it is classified as Device Class Class B. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.